Medical healthcare specialist MetaRobotics continued its strong performance in the third quarter this year.
On the 15th, MetaRobotics said that through the third quarter this year, it posted 110 billion won in sales and 14.9 billion won in operating profit on a consolidation basis. Compared with the same period a year earlier, sales and operating profit increased 18% and 12%, respectively.
METAPHARM, an affiliate that manufactures and distributes pharmaceuticals and medical devices, led the strong results. Driven by subsidiary EZEN Implant, sales rose 63% and operating profit 86% from a year earlier.
MetaRobotics affiliate TechLabs also posted slightly higher sales from a year earlier, based on growth in the healthcare marketing institutional sector and the No. 1 domestic fortunetelling tech platform Jeomsin.
MetaRobotics plans to sustain growth with two pillars: accelerating entry into global markets and advancing TechLabs' platform.
Earlier, on July, it signed a strategic memorandum of understanding (MOU) with YAS Healthcare under DAS Holding, headquartered in Abu Dhabi, United Arab Emirates (UAE), kicking off a full-fledged push into the Middle East market.
A MetaRobotics official said, "Beyond exporting medical devices, we are strengthening global competitiveness by exporting a 'medical K-beauty platform' that integrates medical devices, digital solutions, and brand."